Strategic funding The institute has secured multi-million dollar grants (e.g., $5M from ACRF) and ongoing funding initiatives, signaling strong donor relationships and potential for partnerships or sponsored research programs.

Leadership transition Recent executive leadership changes with a new Executive Director (Dec 2025) and Head of Communications (Apr 2026) present opportunities to engage in strategic messaging, partnership opportunities, and co-branded initiatives aligned with their refreshed vision.

Collaborative tech Active technology and data partnerships (e.g., NetApp collaboration) indicate openness to technology vendors, data analytics, cloud, and storage solutions to accelerate pediatric cancer research programs.

Clinical research programs Ongoing programs such as the ACCEPT early detection and personalized relapse treatments (launched 2017) suggest opportunities for industry sponsorships, clinical trial support services, and translational research collaborations.

Public outreach Strong communication and awareness focus (new Head of Communications) combined with public funding visibility implies potential for education partnerships, patient support platforms, and grant-writing collaboration services.